A retrospective, comparative evaluation of dysglycemias in hospitalized patients receiving gatifloxacin, levofloxacin, ciprofloxacin, or ceftriaxone.
about
Evaluation of the appropriate use of commonly prescribed fluoroquinolones and the risk of dysglycemia.Effect of antibiotics on gut microbiota, glucose metabolism and body weight regulation: a review of the literature.Pharmacotherapy for Hyperglycemia in Noncritically Ill Hospitalized PatientsMoxifloxacin and gatifloxacin for initial therapy of tuberculosis: a meta-analysis of randomized clinical trials.Prevalence of and risk factors for dysglycemia in patients receiving gatifloxacin and levofloxacin in an outpatient setting.Empiric therapy for gram-negative pathogens in nosocomial and health care-associated pneumonia: starting with the end in mind.Cardiovascular and metabolic safety profiles of the fluoroquinolones.Rifampicin loaded mannosylated cationic nanostructured lipid carriers for alveolar macrophage-specific delivery.Risk of gastrointestinal perforation in patients taking oral fluoroquinolone therapy: An analysis of nationally representative cohort.Biomedical Informatics Approaches to Identifying Drug-Drug Interactions: Application to Insulin Secretagogues.Levofloxacin-associated hypoglycaemia complicated by pontine myelinolysis and quadriplegia.Aerosol-based efficient delivery of telithromycin, a ketolide antimicrobial agent, to lung epithelial lining fluid and alveolar macrophages for treatment of respiratory infections.Fluoroquinolone-associated dysglycemias: a tale of two toxicities.Effects of gatifloxacin and levofloxacin on rates of hypoglycemia and hyperglycemia among elderly hospitalized patients.Safety of Delafloxacin: Focus on Adverse Events of Special Interest
P2860
Q35541906-AED6BC3B-3AE1-41D2-BA2A-2A63DE6EA578Q35906455-70AF2EAD-7751-45C8-9E41-9FF618FD09EEQ35912987-CBDFBBCA-70D7-4F89-96E6-5ED547DFE200Q36650622-C748FCE8-633B-46B3-AA0F-ADBFDC317271Q37043542-7EF2404D-446C-4667-AAD9-BFDA0DC6F03EQ37771799-FFF6FE13-4197-4E75-AF5A-004AF6DBF63CQ37940543-88115B52-B0BC-4160-ACDD-501C34B43ABBQ38939434-18CC7FBF-7666-44BE-AF17-718389E1F1BBQ40066337-1A3F589C-9750-4194-8A1D-491C58546E18Q40346427-2F587E2D-627A-49DD-B2F3-485FBB68EF58Q41906764-316574B1-61DA-4B2E-8EBB-1728070A420DQ43048902-846A0454-4783-4ADE-9CCA-2CE694D95523Q46721352-83184614-35BA-4531-8FBD-EE51C767338FQ46929399-AA403425-D3FC-4CED-A3E1-99B478592BD9Q57822396-97D50DFA-4EB1-4D2A-A3AB-1D90A4A8B984
P2860
A retrospective, comparative evaluation of dysglycemias in hospitalized patients receiving gatifloxacin, levofloxacin, ciprofloxacin, or ceftriaxone.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
A retrospective, comparative e ...... ciprofloxacin, or ceftriaxone.
@ast
A retrospective, comparative e ...... ciprofloxacin, or ceftriaxone.
@en
type
label
A retrospective, comparative e ...... ciprofloxacin, or ceftriaxone.
@ast
A retrospective, comparative e ...... ciprofloxacin, or ceftriaxone.
@en
prefLabel
A retrospective, comparative e ...... ciprofloxacin, or ceftriaxone.
@ast
A retrospective, comparative e ...... ciprofloxacin, or ceftriaxone.
@en
P2093
P2860
P1433
P1476
A retrospective, comparative e ...... ciprofloxacin, or ceftriaxone.
@en
P2093
Edward Septimus
Irene Kenton
John F Mohr
Pablo C Okhuysen
Patti J Peymann
Peggy S McKinnon
P2860
P304
P356
10.1592/PHCO.2005.25.10.1303
P407
P577
2005-10-01T00:00:00Z